The rapid rise of cellular therapies is transforming modern medicine and creating new challenges for manufacturers. Unlike traditional biopharmaceuticals, cell-based products demand innovative approaches to aseptic processing, process closure, automation, and scalability.
The rapid rise of cellular therapies is transforming modern medicine and creating new challenges for manufacturers. Unlike traditional biopharmaceuticals, cell-based products demand innovative approaches to aseptic processing, process closure, automation, and scalability. To address these complexities, ISPE and its ATMP Community of Practice have developed a comprehensive ISPE Guide on Equipment...